Arundathy Pandite Nirmalini's Insider Trades & SAST Disclosures
Arundathy Pandite Nirmalini's most recent trade in Shattuck Labs Inc was a trade of 206,200 Common Stock done . Disclosure was reported to the exchange on Jan. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Arundathy Pandite Nirmalini.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 206,200 | 206,200 | - | - | Common Stock | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 25 Jan 2025 | 3,211 | 206,265 | - | 1.2 | 3,725 | Common Stock |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 10 Jan 2025 | 6,884 | 209,476 | - | 1.2 | 8,192 | Common Stock |
| Shattuck Labs Inc | Arundathy Pandite Nirmalini | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.99 per share. | 30 Jan 2024 | 2,920 | 216,360 | - | 10.0 | 29,171 | Common Stock |
| Shattuck Labs Inc | Nirmalini Pandite Arundathy | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Arundathy Pandite Nirmalini | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 46,475 | 222,267 | - | 0 | Common Stock | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. | 10 Jan 2024 | 2,987 | 219,280 | - | 10.1 | 30,139 | Common Stock |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 69,750 | 69,750 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,875 | 175,792 | - | 0 | Common Stock | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.03 per share. | 10 Jan 2023 | 2,987 | 137,917 | - | 3.0 | 9,051 | Common Stock |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 69,475 | 69,475 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 34,738 | 140,904 | - | 0 | Common Stock | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 4,259 | 0 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 10 Aug 2021 | 4,259 | 106,166 | - | 0.0 | 43 | Common Stock |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2021 | 1,604 | 4,259 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 05 Jan 2021 | 1,604 | 101,907 | - | 0.0 | 16 | Common Stock |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 27,563 | 27,563 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges